Stevens Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-126
Closed -$84K 1296
2015
Q1
$84K Buy
+126
New +$83K ﹤0.01% 931
2014
Q4
Sell
-178
Closed -$106K 1281
2014
Q3
$106K Buy
178
+97
+120% +$67.1K ﹤0.01% 928
2014
Q2
$53K Sell
81
-107
-57% -$70.9K ﹤0.01% 1017
2014
Q1
$148K Sell
188
-148
-44% -$120K ﹤0.01% 974
2013
Q4
$259K Sell
336
-56
-14% -$42.2K 0.01% 831
2013
Q3
$301K Buy
392
+215
+121% +$177K 0.01% 788
2013
Q2
$154K Buy
+177
New +$150K 0.01% 837

Other funds holding MTEM

Stevens Capital Management's MTEM Position: Q2 2015 in Review

Stevens Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q2 2015, closing a stake of 126 shares — an estimated $84K sold.

Stevens Capital Management first reported a position in MTEM in Q2 2013 and held it in 7 quarters. The position peaked at $301K in Q3 2013. 85 funds tracked by Wall St. Rank hold MTEM as of Q2 2015.

  • Stevens Capital Management reported no remaining Molecular Templates, Inc. position as of Q2 2015 after selling out during the quarter.
  • Stevens Capital Management sold 126 Molecular Templates, Inc. shares in Q2 2015, an estimated $84K.
  • Stevens Capital Management first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 7 quarters.
  • Stevens Capital Management's Molecular Templates, Inc. position peaked at $301K in Q3 2013.
  • 85 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2015.

Based on Stevens Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.